Feedback / Questions
HORA-PDE6B - Coave Therap
https://www.globenewswire.com/news-release/2024/12/17/2998050/0/en/EyeDNA-Therapeutics-Receives-Rare-Pediatric-Disease-Designation-from-FDA-for-its-Investigational-Gene-Therapy-HORA-PDE6b-for-Patients-with-Retinal-Dystrophy-due-to-PDE6b-Gene-Mutat.html
Dec 17, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next